Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleORIGINAL ARTICLE

A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson's Disease and Traumatic Brain Injury

T. Fahrig, I. Gerlach and E. Horváth
Molecular Pharmacology May 2005, 67 (5) 1544-1555; DOI: https://doi.org/10.1124/mol.104.008177
T. Fahrig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Gerlach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Horváth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 67 no. 5 1544-1555
DOI 
https://doi.org/10.1124/mol.104.008177
PubMed 
15716464

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received October 18, 2004
  • Accepted February 16, 2005
  • Published online April 14, 2005.

Article Versions

  • Earlier version (February 16, 2005 - 12:43).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. T. Fahrig,
  2. I. Gerlach and
  3. E. Horváth
  1. Pharma Research CNS, Bayer HealthCare AG, Wuppertal, Germany
  1. Address correspondence to:
    Thomas Fahrig, BHC-PH-PD-PT, Bayer HealthCare AG, D-51368 Leverkusen, Germany. E-mail: thomas.fahrig{at}bayerhealthcare.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2005 to October 2023

AbstractFullPdf
Feb 200519068
Mar 200528046
Apr 2005572573
May 2005417041
Jun 2005317579
Jul 2005266434
Aug 2005266244
Sep 200583928
Oct 2005153119
Nov 200572519
Dec 2005233723
Jan 2006131217
Feb 20062069
Mar 2006251216
Apr 2006131011
May 2006113038
Jun 2006193036
Jul 2006131920
Aug 200611515
Sep 200683029
Oct 2006142232
Nov 2006181827
Dec 2006131719
Jan 200761322
Feb 2007111921
Mar 2007152433
Apr 2007113035
May 2007151843
Jun 200782034
Jul 200721315
Aug 2007142333
Sep 200781413
Oct 2007102226
Nov 200732127
Dec 2007122532
Jan 200831720
Feb 2008201222
Mar 2008333130
Apr 2008201618
May 2008301413
Jun 2008211721
Jul 2008221524
Aug 2008114158
Sep 2008501921
Oct 2008351717
Nov 2008191611
Dec 2008639
Jan 2009141522
Feb 2009121716
Mar 2009212215
Apr 2009191616
May 2009132115
Jun 20096129
Jul 200911147
Aug 200918719
Sep 2009131210
Oct 200920591
Nov 200913410
Dec 200928585
Jan 2010581616
Feb 201040912
Mar 2010131220
Apr 20102369
May 20102175
Jun 2010671913
Jul 2010412114
Aug 2010431513
Sep 20102382
Oct 2010161113
Nov 2010162319
Dec 201012811
Jan 2011151317
Feb 20116810
Mar 201128913
Apr 20119813
May 201171123
Jun 201181220
Jul 2011101733
Aug 201111235
Sep 201191922
Oct 201131823
Nov 2011111822
Dec 201151629
Jan 2012111539
Feb 201261024
Mar 201291327
Apr 2012162132
May 201282427
Jun 20128524
Jul 2012131034
Aug 201271427
Sep 2012101329
Oct 201291246
Nov 2012172035
Dec 201220827
Jan 2013141015
Feb 20139917
Mar 201313519
Apr 2013291527
May 2013111324
Jun 2013665
Jul 20131136
Aug 20138518
Sep 201315913
Oct 2013934
Nov 20137611
Dec 2013599
Jan 20142465
Feb 2014879
Mar 201417713
Apr 201413148
May 2014152522
Jun 201410118
Jul 201416357
Aug 20141166
Sep 201421412
Oct 20141087
Nov 20141969
Dec 201412137
Jan 201517118
Feb 2015542
Mar 20151466
Apr 201512108
May 201517218
Jun 20155165
Jul 2015191414
Aug 201510145
Sep 2015494
Oct 2015111416
Nov 2015722
Dec 20157119
Jan 20161758
Feb 2016111313
Mar 20161458
Apr 20167610
May 201621111
Jun 2016475
Jul 2016378
Aug 2016344
Sep 2016782
Oct 20163139
Nov 2016785
Dec 20160201
Jan 20171148
Feb 2017161
Mar 20171147
Apr 20170101
May 2017292
Jun 20172123
Jul 20173204
Aug 20170102
Sep 20171177
Oct 20175206
Nov 20170237
Dec 20172245
Jan 20181298
Feb 20182236
Mar 20181164
Apr 20183183
May 2018166
Jun 20180133
Jul 2018095
Aug 20180144
Sep 2018075
Oct 201801011
Nov 20180100
Dec 20184213
Jan 20195175
Feb 20196213
Mar 20193212
Apr 20191234
May 20191706
Jun 201914111
Jul 20192122
Aug 20191601
Sep 20192400
Oct 2019600
Nov 2019912
Dec 20191110
Jan 20201310
Feb 20202010
Mar 20201900
Apr 2020500
May 20201310
Jun 2020400
Jul 20201121
Aug 2020916
Sep 20201000
Oct 20201012
Nov 2020812
Dec 2020900
Jan 20211113
Feb 20212224
Mar 20211923
Apr 2021410
May 20211124
Jun 2021410
Jul 20211612
Aug 20211511
Sep 20211801
Oct 20213020
Nov 20211614
Dec 20211117
Jan 20221702
Feb 2022812
Mar 20221220
Apr 2022530
May 20221513
Jun 20222600
Jul 20221623
Aug 20222248
Sep 20221000
Oct 20221821
Nov 2022613
Dec 20221321
Jan 20232110
Feb 20231721
Mar 20231310
Apr 20233322
May 20231814
Jun 20231331
Jul 20231922
Aug 20232237
Sep 2023810
Oct 2023100

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 67 (5)
Molecular Pharmacology
Vol. 67, Issue 5
1 May 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson's Disease and Traumatic Brain Injury
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleORIGINAL ARTICLE

A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson's Disease and Traumatic Brain Injury

T. Fahrig, I. Gerlach and E. Horváth
Molecular Pharmacology May 1, 2005, 67 (5) 1544-1555; DOI: https://doi.org/10.1124/mol.104.008177

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleORIGINAL ARTICLE

A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson's Disease and Traumatic Brain Injury

T. Fahrig, I. Gerlach and E. Horváth
Molecular Pharmacology May 1, 2005, 67 (5) 1544-1555; DOI: https://doi.org/10.1124/mol.104.008177
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The 73-kDa Heat Shock Cognate Protein Is a CXCR4 Binding Protein that Regulates the Receptor Endocytosis and the Receptor-Mediated Chemotaxis
  • Endogenous Regulator of G-Protein Signaling Proteins Regulate the Kinetics of Gαq/11-Mediated Modulation of Ion Channels in Central Nervous System Neurons
  • A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling
Show more ORIGINAL ARTICLE

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics